ampicillin has been researched along with bismuth in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Seppälä, K | 1 |
| Littlewood, JM; Mahony, MJ; Wyatt, JI | 1 |
| Chisari, G; Gismondo, MR; Lo Bue, AM; Malandrino, G; Pecorella, G; Petralito, E | 1 |
| Chiasson, D; Cutz, E; Drumm, B; Karmali, M; Sherman, P | 1 |
| Coudron, PE; Stratton, CW | 2 |
| Kihira, K; Kimura, K; Sato, K; Takimoto, T; Taniguchi, Y; Yoshida, Y | 1 |
| Cheng, AF; Chung, SS; Ling, TK; Sung, JJ; Yiu, PY | 1 |
| Angeles Arpa, M; Bermejo, F; Boixeda, D; García Arata, I; García Plaza, A; Gisbert, JP; Jesús Higes, M; Martín de Argila, C; Nieves Rincón, M | 1 |
| Pistiolas, D; Robotis, J; Rokkas, T; Sechopoulos, P | 1 |
| Priya, B; Raizada, P; Singh, N; Singh, P; Thakur, P | 1 |
| Alsamman, MA; Argueta, EA; D'Agata, EMC; Moss, SF | 1 |
1 review(s) available for ampicillin and bismuth
| Article | Year |
|---|---|
[Should Helicobacter infection be treated?].
Topics: Ampicillin; Bismuth; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole | 1991 |
1 trial(s) available for ampicillin and bismuth
| Article | Year |
|---|---|
[The effect of the eradication of H. pylori on the intractable ulcer].
Topics: Ampicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Recurrence | 1993 |
11 other study(ies) available for ampicillin and bismuth
| Article | Year |
|---|---|
Management and response to treatment of Helicobacter pylori gastritis.
Topics: Age Factors; Ampicillin; Antacids; Biopsy; Bismuth; Child; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Prevalence; Prospective Studies; Sex Factors; Socioeconomic Factors | 1992 |
[Competitive activity of a bacterial preparation on colonization and pathogenicity of C. pylori. A clinical study].
Topics: Adult; Aged; Ampicillin; Bifidobacterium; Bismuth; Campylobacter Infections; Campylobacter jejuni; Colloids; Duodenitis; Female; Gastritis; Humans; Lactobacillus acidophilus; Male; Middle Aged | 1990 |
Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin.
Topics: Adolescent; Ampicillin; Bismuth; Campylobacter; Campylobacter Infections; Child; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Humans; Organometallic Compounds; Pyloric Antrum; Salicylates | 1988 |
Adverse Drug Reactions Advisory Committee report for 1973.
Topics: Adolescent; Adult; Age Factors; Aged; Ampicillin; Anesthetics, Local; Antipsychotic Agents; Australia; Bismuth; Catecholamines; Child; Child, Preschool; Computers; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Male; Middle Aged; Nervous System Diseases; Phenothiazines; Pimozide; Quinolines; Sex Factors | 1974 |
Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.
Topics: Ampicillin; Bismuth; Drug Combinations; Drug Evaluation; Helicobacter pylori; Kinetics; Microbial Sensitivity Tests; Time Factors | 1995 |
An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Imipenem; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Tetracycline | 1996 |
The bactericidal activity of clarithromycin versus ampicillin alone and in combination with omeprazole and/or bismuth against clarithromycin-susceptible and clarithromycin-resistant strains of Helicobacter pylori.
Topics: Ampicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Interactions; Drug Resistance, Microbial; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Omeprazole; Pyloric Antrum; Sensitivity and Specificity; Species Specificity | 1998 |
Re-treatment after Helicobacter pylori eradication failure.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Treatment Failure | 1999 |
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
Topics: Amoxicillin; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Omeprazole; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
Adsorptional photocatalytic mineralization of oxytetracycline and ampicillin antibiotics using Bi2O3/BiOCl supported on graphene sand composite and chitosan.
Topics: Adsorption; Ampicillin; Anti-Bacterial Agents; Bismuth; Catalysis; Chitosan; Graphite; Kinetics; Oxytetracycline; Particle Size; Photochemical Processes; Surface Properties | 2016 |
Impact of Antimicrobial Resistance Rates on Eradication of Helicobacter pylori in a US Population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Bismuth; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Rhode Island; Rifabutin; Tetracycline; Young Adult | 2021 |